Moreover, the crucial role of EP1 in CRC has also been demonstrated with AOM-treated mice, in which an EP1-selective antagonist (ONO-8711) reduced the numbers of intestinal polyps and diminished tumor development [88]. This evidence concerns the gene PTGER1 and colorectal carcinoma.